Birgitta Carlé Selected Research

Ligands

1/2019

Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Birgitta Carlé Research Topics

Disease

3	Colitis 11/2022 - 01/2019
2	Fibrosis (Cirrhosis) 11/2019 - 01/2019
2	Inflammation (Inflammations) 11/2019 - 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Neoplasms (Cancer) 11/2019
1	Edema (Dropsy) 11/2019
1	Ulcerative Colitis 01/2019

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 11/2019 - 01/2019
1	Dextran SulfateIBA 11/2022
1	OxazoloneIBA 11/2022
1	Death-Associated Protein KinasesIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	integrin alpha4beta7IBA 11/2019
1	IntegrinsIBA 11/2019
1	CytokinesIBA 11/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	InterleukinsIBA 01/2019
1	LigandsIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Collagen Type VIIBA 01/2019
1	CollagenIBA 01/2019

Therapy/Procedure

1	Therapeutics 11/2022
1	Injections 01/2019